J.P. Morgan Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $24
Healthpeak Properties Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $26
Healthpeak Properties Analyst Ratings
Scotiabank Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $24
Scotiabank Reaffirms Their Buy Rating on Healthpeak Properties (DOC)
Scotiabank Adjusts Healthpeak Properties Price Target to $24 From $23
Healthpeak Properties Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $23.5
Healthpeak Properties Hold Rating: Balancing Merger Benefits Against Lab Space Market Risks
Healthpeak Properties Analyst Ratings
Citigroup Adjusts Price Target on Healthpeak Properties to $22 From $20, Maintains Neutral Rating
Citi Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $22
Wells Fargo Remains a Hold on Healthpeak Properties (DOC)
Buy Rating Justified by Strategic Growth and Strong Performance in Healthpeak Properties
Jefferies Adjusts Price Target on Healthpeak Properties to $25 From $22
Jefferies Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25
RBC Capital Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25
BMO Capital Adjusts Price Target on Healthpeak Properties to $26 From $23, Maintains Outperform Rating
No Data
No Data